Evidence map›Paper›PMID 38146036›Full record

ArticleWorld journal of microbiology & biotechnology2023

Rapid visual nucleic acid detection of Vibrio alginolyticus by recombinase polymerase amplification combined with CRISPR/Cas13a.

Yanan Wang, Yachao Hou, Xinping Liu, Na Lin, Youyou Dong, Fei Liu, Wenrong Xia, Yongqi Zhao, Weiwei Xing, Jin Chen and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Molecular Diagnostics of PathogenicInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yanan WangDepartment of Clinical Laboratory, The Six Medical Center of PLA General Hospital, No. 6 Fucheng Road, Beijing, 100048, China.
Yachao HouDepartment of Clinical Laboratory, The Six Medical Center of PLA General Hospital, No. 6 Fucheng Road, Beijing, 100048, China.
Xinping LiuDepartment of Clinical Laboratory, The Six Medical Center of PLA General Hospital, No. 6 Fucheng Road, Beijing, 100048, China.
Na LinInstitute of Clinical Laboratory, The 900Th Hospital, Xiamen University, Fuzhou, China.
Youyou DongDepartment of Clinical Laboratory, The Six Medical Center of PLA General Hospital, No. 6 Fucheng Road, Beijing, 100048, China.
Fei LiuInstitute of Clinical Laboratory, The 900Th Hospital, Xiamen University, Fuzhou, China.
Wenrong XiaBei Jing Institute of Basic Medical Sciences, Beijing, China.
Yongqi ZhaoBei Jing Institute of Basic Medical Sciences, Beijing, China.
Weiwei XingBei Jing Institute of Basic Medical Sciences, Beijing, China. huozinangua@163.com.
Jin ChenInstitute of Clinical Laboratory, The 900Th Hospital, Xiamen University, Fuzhou, China. kingchen81@qq.com.
Changguo ChenDepartment of Clinical Laboratory, The Six Medical Center of PLA General Hospital, No. 6 Fucheng Road, Beijing, 100048, China. 1234_chen@sina.com.
Chinese PLA General Hospital · CNXiamen University · CNBeijing Institute of Education · CNInstitute of Basic Medical Sciences of the Chinese Academy of Medical Sciences

Funding

National Natural Science Foundation of China No.81401311
6 · The paper itself

Abstract

Vibrio alginolyticus (V. alginolyticus) is a common pathogen in the ocean. In addition to causing serious economic losses in aquaculture, it can also infect humans. The rapid detection of nucleic acids of V. alginolyticus with high sensitivity and specificity in the field is very important for the diagnosis and treatment of infection caused by V. alginolyticus. Here, we established a simple, fast and effective molecular method for the identification of V. alginolyticus that does not rely on expensive instruments and professionals. The method integrates recombinase polymerase amplification (RPA) technology with CRISPR system in a single PCR tube. Using this method, the results can be visualized by lateral flow dipstick (LFD) in less than 50 min, we named this method RPA-CRISPR/Cas13a-LFD. The method was confirmed to achieve high specificity for the detection of V. alginolyticus with no cross-reactivity with similar Vibrio and common clinical pathogens. This diagnostic method shows high sensitivity; the detection limit of the RPA-CRISPR/Cas13a-LFD is 10 copies/µL. We successfully identified 35 V. alginolyticus strains from a total of 55 different bacterial isolates and confirmed their identity by (Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, MALDI-TOF MS). We also applied this method on infected mice blood, and the results were both easily and rapidly obtained. In conclusion, RPA-CRISPR/Cas13a-LFD offers great potential as a useful tool for reliable and rapid diagnosis of V. alginolyticus infection, especially in limited conditions.

Indexed as

RecombinasesVibrio alginolyticusAnimalsClustered Regularly Interspaced Short Palindromic RepeatsHumansMiceNucleic Acid Amplification TechniquesPolymerase Chain ReactionSensitivity and SpecificityRecombinasesCRISPR/Cas13aLateral flow dipstickNucleic acid detectionRecombinase polymerase amplificationVibrio alginolyticus

Identifiers

PMID38146036
OpenAlexW4390205599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.